Donald Trump's Suspension of USAID: How African leaders should respond to antiretroviral (ARV) drug shortages, by Abubakar M. Kareto African leaders and African countries must adopt a strategic and logical approach in responding to Donald J. Trump's decision to suspend USAID. The US is a major manufacturer of HIV/AIDS drugs, and it's not only USAID that patronises American pharmaceutical companies; many other organisations do too. In 2023, triple HIV therapy generated worldwide sales of roughly $12 billion for a U.S. company called Gilead. This resulted in significant revenue generation and the...